CTA-PB · EIDP, Inc. · Financials
Market Cap
$6,595
Shares
100
Volume · Oct 20
5460
Avg daily vol (3M)
3203
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$24.59B
-2.1%
FY2016
Net Income
$2.51B
+28.7%
FY2016
Gross Margin
41.17%
+1.3pp
FY2016
Operating Margin
22.38%
+3.9pp
FY2014
Diluted EPS
$2.85
+31.9%
FY2016
Operating Cash Flow
$3.3B
+42.5%
FY2016
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | $24.59B | $25.13B | $28.41B | $29B | $34.81B | $33.68B | $27.7B | $26.11B | $30.53B | |
| — | — | $14.47B | $15.11B | $17.02B | $17.64B | $21.4B | $21.26B | — | — | — | |
| — | — | $10.13B | $10.02B | $11.38B | $11.36B | $13.41B | $12.42B | — | — | — | |
| — | — | 41.17% | 39.86% | 40.07% | 39.16% | 38.53% | 36.87% | — | — | — | |
| — | — | $1.64B | $1.9B | $1.96B | $2.04B | $2.12B | $1.96B | $1.6B | $1.38B | $1.39B | |
| — | — | $4.32B | $4.62B | $4.89B | $5.34B | $5.89B | $3.31B | $2.91B | $3.44B | $3.59B | |
| — | — | $319M | $362M | $363M | $323M | $337M | $277M | $176M | $252M | $275M | |
| — | — | $1.26B | $1.47B | $1.62B | $1.6B | $1.71B | $1.56B | $1.38B | $1.5B | — | |
| — | — | — | — | — | — | — | $50M | -$34M | $210M | $535M | |
| — | $28.62B | — | — | $31.06B | $32.66B | $32.22B | $30.54B | $25.64B | $25.14B | $29.45B | |
| — | $5.63B | — | — | $6.36B | $5.37B | $5.37B | $5.88B | $4.61B | $3.34B | — | |
| — | — | — | — | 22.38% | 18.52% | 15.42% | 17.46% | 16.65% | 12.79% | — | |
| — | — | — | — | $7.97B | $6.97B | $7.08B | $7.44B | $5.99B | $4.84B | — | |
| — | — | $107M | $129M | $129M | $136M | $109M | $110M | $92M | $91M | $138M | |
| — | — | $99M | $49M | -$36M | $22M | $102M | $192M | $177M | $99M | $81M | |
| — | — | $3.27B | $2.59B | $4.31B | $2.57B | $3.09B | $3.88B | $3.26B | $2.18B | $2.39B | |
| — | — | $744M | $696M | $1.17B | $360M | $616M | $647M | $515M | $415M | $381M | |
| — | — | $2.51B | $1.95B | $3.63B | $4.85B | $2.76B | $3.56B | $3.03B | $1.76B | $2.01B | |
| — | — | 10.22% | 7.77% | 12.76% | 16.72% | 7.91% | 10.57% | 10.94% | 6.72% | 6.57% | |
| — | — | $12M | $6M | $11M | $14M | $25M | $40M | $21M | $14M | $3M | |
| — | $2.23B | $2.5B | $1.94B | $3.62B | $4.84B | $2.75B | $3.55B | $3.02B | $1.75B | $2B | |
| — | — | $2B | $645M | $359M | $8.05B | $2.86B | $599M | $3.01B | — | — | |
| USD/shares | — | $2.58 | $2.87 | $2.17 | $3.95 | $5.22 | $2.94 | $3.82 | $3.32 | $1.93 | $2.21 |
| USD/shares | $3.60 – $3.80* | $2.56 | $2.85 | $2.16 | $3.92 | $5.18 | $2.91 | $3.77 | $3.28 | $1.92 | $2.20 |
| shares | — | — | 872.56M | 893.99M | 914.75M | 925.98M | 933.28M | 928.42M | 908.86M | 904.4M | 902.42M |
| shares | — | — | 877.04M | 899.53M | 921.87M | 933.15M | 942.2M | 941.03M | 921.66M | 908.71M | 907.37M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2016: $7.59B in buybacks.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Seed | $9,898,000,000 | $9,545,000,000 | $9,472,000,000 | $8,979,000,000 | $8,402,000,000 | $7,756,000,000 | $7,590,000,000 | $7,842,000,000 |
| Crop Protection | $7,503,000,000 | $7,363,000,000 | $7,754,000,000 | $8,476,000,000 | $7,253,000,000 | $6,461,000,000 | $6,256,000,000 | $6,445,000,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $8,269,000,000 | $7,866,000,000 | $7,783,000,000 | $7,553,000,000 | $6,782,000,000 | $6,510,000,000 | $6,255,000,000 | $6,725,000,000 |
| Latin America | $3,928,000,000 | $3,776,000,000 | $3,906,000,000 | $4,445,000,000 | $3,545,000,000 | $2,805,000,000 | $2,889,000,000 | $2,817,000,000 |
| EMEA | $3,110,000,000 | $3,124,000,000 | $3,367,000,000 | $3,256,000,000 | $3,123,000,000 | $2,842,000,000 | $2,740,000,000 | $2,765,000,000 |
| Brazil | $2,900,000,000 | $2,618,000,000 | $2,523,000,000 | $3,137,000,000 | $2,315,000,000 | $1,724,000,000 | $1,794,000,000 | $1,732,000,000 |
| Asia Pacific | $1,339,000,000 | $1,348,000,000 | $1,363,000,000 | $1,460,000,000 | $1,451,000,000 | $1,402,000,000 | $1,288,000,000 | $1,293,000,000 |
| Canada | $755,000,000 | $794,000,000 | $807,000,000 | $741,000,000 | $754,000,000 | $658,000,000 | $674,000,000 | $687,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Corn | $7,002,000,000 | $6,496,000,000 | $6,447,000,000 | $5,955,000,000 | $5,618,000,000 | $5,182,000,000 | $5,126,000,000 | $5,220,000,000 |
| Herbicides | $3,730,000,000 | $3,599,000,000 | $4,034,000,000 | $4,591,000,000 | $3,815,000,000 | $3,280,000,000 | $3,206,000,000 | $3,413,000,000 |
| Soybean | $1,878,000,000 | $1,927,000,000 | $1,858,000,000 | $1,810,000,000 | $1,568,000,000 | $1,445,000,000 | $1,387,000,000 | $1,497,000,000 |
| Insecticides | $1,669,000,000 | $1,715,000,000 | $1,598,000,000 | $1,831,000,000 | $1,730,000,000 | $1,764,000,000 | $1,652,000,000 | $1,506,000,000 |
| Fungicides | $1,140,000,000 | $1,081,000,000 | $1,112,000,000 | $1,450,000,000 | $1,310,000,000 | $1,032,000,000 | $1,072,000,000 | $1,142,000,000 |
| Other | $819,000,000 | $961,000,000 | $978,000,000 | $1,041,000,000 | $862,000,000 | $895,000,000 | $810,000,000 | $864,000,000 |
| Other Oilseeds | $644,000,000 | $653,000,000 | $708,000,000 | $714,000,000 | $752,000,000 | $619,000,000 | $593,000,000 | $645,000,000 |
| Biologicals | $519,000,000 | $476,000,000 | $491,000,000 | $63,000,000 | — | — | — | — |
| Corn | — | — | — | — | — | — | $5,111,000,000 | $5,180,000,000 |
| Fungicides | — | — | — | — | — | — | $1,081,000,000 | $1,142,000,000 |
| Herbicides | — | — | — | — | — | — | $3,270,000,000 | $3,415,000,000 |
| Other | — | — | — | — | — | — | $800,000,000 | $943,000,000 |
| Other Oilseeds | — | — | — | — | — | — | $561,000,000 | $607,000,000 |
| Soybean | — | — | — | — | — | — | $1,371,000,000 | $1,494,000,000 |